-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 JL3o3hlt4V09ihBU2KZGU+YO+FTi4kuoylW8aiLA0BJj1NzqSkflttfK+HrBAr+0
 iJAySbH2Kt7HFrio1ZkWfw==

<SEC-DOCUMENT>0001191638-08-001144.txt : 20080624
<SEC-HEADER>0001191638-08-001144.hdr.sgml : 20080624
<ACCEPTANCE-DATETIME>20080624110913
ACCESSION NUMBER:		0001191638-08-001144
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20080624
FILED AS OF DATE:		20080624
DATE AS OF CHANGE:		20080624

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UNILEVER PLC
		CENTRAL INDEX KEY:			0000217410
		STANDARD INDUSTRIAL CLASSIFICATION:	FOOD & KINDRED PRODUCTS [2000]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-04546
		FILM NUMBER:		08913598

	BUSINESS ADDRESS:	
		STREET 1:		UNILEVER HOUSE
		STREET 2:		BLACKFRIARS
		CITY:			LONDON ENGLAND
		STATE:			X0
		ZIP:			EC4P 4BQ
		BUSINESS PHONE:		201-894-2790

	MAIL ADDRESS:	
		STREET 1:		C/O UNILEVER UNITED STATES INC
		STREET 2:		700 SYLVAN AVENUE  (ATTN.: M MONTAGNINO)
		CITY:			ENGLEWOOD CLIFFS
		STATE:			NJ
		ZIP:			07632

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	UNILEVER LTD
		DATE OF NAME CHANGE:	19820429
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ulvr200806246k.htm
<DESCRIPTION>GENEVIEVE BERGER TO BE CHIEF R&D OFFICER
<TEXT>
<html>
    <head>
        <title></title>
        <!-- Created by EDGAR Ease Plus (EDGAR Ease+) -->
        <!-- Control Number:                                                                  -->
        <!-- Rev Number:                                                                      -->
        <!-- Client Name:                                                                     -->
        <!-- Project Name:                                                                    -->
        <!-- Firm Name:                                                                       -->
    </head>

    <body text="#000000" vlink="#800000" link="#0000ff" bgcolor="#ffffff">
        <p align="center"><strong>FORM 6-K<br>
        SECURITIES AND EXCHANGE COMMISSION<br>
        Washington, D.C. 20549</strong></p>

        <p align="center"><br>
        <strong>REPORT OF FOREIGN ISSUER</strong></p>

        <p align="center"><br>
        <strong>Pursuant to Rule 13a-16 or 15d-16<br>
        of the Securities Exchange Act of 1934</strong></p>

        <p align="center"><br>
        For the month of&nbsp; June 2008</p>

        <p align="center">
        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>

        <strong>UNILEVER PLC&nbsp;&nbsp;&nbsp;&nbsp;<br>
        </strong> (Translation of registrant's name into English)</p>

        <p align="center"><strong>UNILEVER HOUSE, BLACKFRIARS, LONDON, ENGLAND</strong><br>
        (Address of principal executive offices)</p>

        <p align="center"><br>
        Indicate by check mark whether the registrant files or will file annual reports<br>
        under cover Form 20-F or Form 40-F.</p>

        <p align="center">Form 20-F..X.. Form 40-F.....</p>

        <p align="center">Indicate by check mark if the registrant is submitting the Form 6-K in
        paper<br>
        as permitted by Regulation S-T Rule 101(b)(1):_____</p>

        <p align="center">Indicate by check mark if the registrant is submitting the Form 6-K in
        paper<br>
        as permitted by Regulation S-T Rule 101(b)(7):_____</p>

        <p align="center"><br>
        Indicate by check mark whether the registrant by furnishing the information<br>
        contained in this Form is also thereby furnishing the information to the<br>
        Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.</p>

        <p align="center">Yes ..... No .X..</p>

        <p align="center">If "Yes" is marked, indicate below the file number assigned to the
        registrant<br>
        in connection with Rule 12g3-2(b): 82- _______</p>

        <p>&nbsp;</p>

        <p>Exhibit 99 attached hereto is incorporated herein by reference.</p>

        <p>&nbsp;</p>

        <p align="center"><strong>Signatures</strong></p>

        <p>Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has
        duly caused this report to be signed on its behalf by the undersigned, thereunto duly
        authorized.</p>

        <p>&nbsp;</p>

        <p>
        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
        UNILEVER PLC<br>
        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

        <p>
        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/S/
        S H M A Dumoulin<br>
        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
        By&nbsp; S H M A Dumoulin<br>
        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
        Secretary<br>
        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>

        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>

        Date: 24 June 2008</p>

        <p>&nbsp;</p>

        <p>&nbsp;</p>

        <p>
        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
        &nbsp;&nbsp;&nbsp;&nbsp; EXHIBIT INDEX<br>
        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
        &nbsp;-------------</p>

        <p>EXHIBIT
        NUMBER&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
        EXHIBIT DESCRIPTION</p>

        <p>
        99&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
        &nbsp;&nbsp; &nbsp;Notice to London Stock Exchange dated 24 June 2008<br>
        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
        &nbsp; Genevieve Berger to be Chief R&amp;D Officer</p>

        <p><br>
        &nbsp;</p>

        <p>Exhibit 99</p>

        <p>&nbsp;</p>

        <p class="c2"><strong><font size="5">GENEVI&Egrave;VE BERGER TO BE CHIEF R&amp;D
        OFFICER</font></strong></p>

        <p class="c3"><strong><br>
        </strong></p>

        <p class="c3">Unilever today announced that Professor Genevi&egrave;ve Berger (PhD, MD) has
        been appointed as its chief research and development officer. Professor Berger, who is
        currently professor of medicine at Pierre and Marie Curie University and at La
        Piti&eacute;-Salp&eacute;tri&egrave;re Teaching Hospital in Paris, will report directly to
        group chief executive, Patrick Cescau, and will join his executive team.<br>
        <br>
        In her new role Professor Berger will be the functional leader for research and development
        in Unilever and will directly lead all the resources and major laboratories dedicated to
        the company's focus on scientific discovery. She will be responsible for Unilever's Safety
        and Environmental Assurance Centre (SEAC) as well as advising the executive on all matters
        of science and technology.<br>
        <br>
        Patrick Cescau, group chief executive, said: "I am extremely pleased to be able to welcome
        Genevi&egrave;ve to my team as an executive member. The contribution she has made to the
        business as a non-executive was outstanding and served to demonstrate to us how much more
        she could achieve in a full-time capacity. She will bring to Unilever her strong
        inter-disciplinary background, as well as her expertise in managing science."<br>
        <br>
        Genevi&egrave;ve Berger, said:"I am delighted to be joining Unilever in this exciting role.
        During my time as a non-executive director I have been hugely impressed by Unilever's
        commitment to science and to R&amp;D in particular, but felt that the contribution that I
        could make was limited by time. I am hugely grateful to Patrick for giving me the
        opportunity to lead the function and to use my knowledge on a full-time basis."<br>
        <br>
        Michael Treschow, chairman of Unilever, said: "I fully support the appointment of Professor
        Berger to this new executive position. In the short time that she was on the board her
        contribution to our understanding of scientific and technical matters was exceptional and I
        am sure that she will be better placed to serve Unilever by being a full-time member of
        Patrick's executive team."<br>
        <br>
        Professor Genevi&egrave;ve Berger, 53, will step down from the boards of Unilever plc and
        Unilever N.V., where she is currently a non-executive director.<br>
        <br>
        Professor Berger will take up her new position at the beginning of July and at the same
        time will leave her current position at Pierre and Marie Curie University<br>
        </p>

        <p class="c8"><font face="Arial">-ends-</font></p>

        <p class="c3"><font face="Arial"><br>
        </font></p>

        <p class="c10"><u><strong><font face="Arial">Notes:</font></strong></u></p>

        <p class="c3"><u><br>
        </u></p>

        <p class="c10"><strong><font face="Arial">Professor Genevi&egrave;ve
        Berger</font></strong></p>

        <p class="c3"><strong><br>
        </strong></p>

        <p class="c3">Genevi&egrave;ve Berger was born in France in 1955 and was educated in
        physics and medicine. She has three doctorates: a PhD in Physics, a PhD in Human Biology
        and a Medical Doctorate.<br>
        <br>
        In 1996, she was appointed University Professor in medicine at Pierre and Marie Curie
        University (Paris)I and, since 2003, has worked in La
        Piti&eacute;-Salp&eacute;tri&egrave;re Teaching Hospital as a professor and hospital
        practitioner.</p>

        <p class="c3"><br>
        </p>

        <p class="c12">Genevi&egrave;ve's accomplishments include serving as the director of the
        Biotech and Agri-Food Department at the French Ministry for Education, Research and
        Technology (1998-2000) and her appointment as Head of the Technology Directorate at the
        French Ministry of Research in 2000. Between 2000 and 2003, she was also Director General
        of the CNRS (Centre National de la Recherche Scientifique) which is one of the world's
        largest research organisation with some 26,000 employees.</p>

        <p class="c3"><br>
        </p>

        <p class="c12">She is currently a member of the Technical Program Committee of the
        Institute of Electrical and Electronics Engineers (IEEE) on ultrasonics, ferroelectrics and
        frequency control and the Chairman of the Advisory Group - Health for the European
        Commission.</p>

        <p class="c3"><br>
        </p>

        <p class="c12">The author of numerous publications and patents, her many honours and awards
        include the CNRS Silver Medal for the Life Sciences (1994), Yves Rocard Prize from the
        French Physics Society (1997), the European Grand Prix for Innovation Award (2001) and the
        American Institute of Ultrasound in Medicine (AIUM) Honorary Fellow Award (2006).</p>

        <p class="c3"><br>
        </p>

        <p class="c3"><br>
        </p>

        <p class="c12"><strong><font size="2">About Unilever</font></strong></p>

        <p class="c3"><strong><br>
        </strong></p>

        <p class="c12"><font size="2">Unilever's mission is to add vitality to life. We meet
        everyday needs for nutrition, hygiene and personal care with brands that help people feel
        good, look good and get more out of life.</font></p>

        <p class="c3"><font size="2"><br>
        </font></p>

        <p class="c12"><font size="2">Unilever is one of the world's leading suppliers of fast
        moving consumer goods with strong local roots in more than 100 countries across the globe.
        Its portfolio includes some of the world's best known and most loved brands including
        twelve &euro;1 billion brands and global leadership in many categories in which the company
        operates. The portfolio features brand icons such as Flora, Bertolli, Dove, Lux, Pond's,
        Lynx, Sunsilk, Persil, Cif and Domestos.&nbsp;</font></p>

        <p class="c3"><font size="2"><br>
        </font></p>

        <p class="c12"><font size="2">Unilever has around 174,000 employees in approaching 100
        countries and generated annual sales of&nbsp;&euro;40&nbsp;billion in 2007. For more
        information about Unilever and its brands, visit&nbsp;</font>
        <font size="+0">www.unilever.com</font><font size="2">.</font></p>

        <p class="c3"><font size="2"><br>
        </font></p>

        <p class="c3"><font size="2"><br>
        </font></p>

        <p class="c12"><strong><font size="2">SAFE HARBOUR STATEMENT:</font></strong></p>

        <p class="c12"><font size="2">This announcement may contain forward-looking statements,
        including 'forward-looking statements' within the meaning of the United States Private
        Securities Litigation Reform Act of 1995. Words such as 'expects', 'anticipates', 'intends'
        or the negative of these terms and other similar expressions of future performance or
        results, including financial objectives to 2010, and their negatives are intended to
        identify such forward-looking statements. These forward-looking statements are based upon
        current expectations and assumptions regarding anticipated developments and other factors
        affecting the Group. They are not historical facts, nor are they guarantees of future
        performance. Because these forward-looking statements involve risks and uncertainties,
        there are important factors that could cause actual results to differ materially from those
        expressed or implied by these forward-looking statements, including, among others,
        competitive pricing and activities, consumption levels, costs, the ability to maintain and
        manage key customer relationships and supply chain sources, currency values, interest
        rates, the ability to integrate acquisitions and complete planned divestitures, physical
        risks, environmental risks, the ability to manage regulatory, tax and legal matters and
        resolve pending matters within current estimates, legislative, fiscal and regulatory
        developments, political, economic and social conditions in the geographic markets where the
        Group operates and new or changed priorities of the Boards. Further details of potential
        risks and uncertainties affecting the Group are described in the Group's filings with the
        London Stock Exchange, Euronext Amsterdam and the US Securities and Exchange Commission,
        including the Annual Report &amp; Accounts on Form 20-F. These forward-looking statements
        speak only as of the date of this announcement. Except as required by any applicable law or
        regulation, the Group expressly disclaims any obligation or undertaking to release publicly
        any updates or revisions to any forward-looking statements contained herein to reflect any
        change in the Group's expectations with regard thereto or any change in events, conditions
        or circumstances on which any such statement is based.</font></p>

        <div style="DISPLAY: inline">
            &nbsp;
        </div>
    </body>
</html>

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
